Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2 Colorectal Neoplasms 2 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Pancreatic Neoplasms 1 Paclitaxel-induced Neuropathy 1 Obesity 1 Neoplasms 1 Insulin Resistance 1 Hyperandrogenism 1 Hirsutism 1 Dyslipidemias 1 Agnosia 1 AML 1

Interventions

Bupivacaine 11 Ketamine 9 Ropivacaine 8 Morphine 8 Analgesics, Opioid 8 Acetaminophen 8 Fentanyl 7 Dexmedetomidine 7 Lidocaine 6 Anesthesia, General 6 Saline Solution 5 Anesthesia, Local 5 Acupuncture Therapy 5 parecoxib 4 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Analgesia, Epidural 4 Transcutaneous Electric Nerve Stimulation 3 Radiofrequency Ablation 3 Propofol 3 Oxycodone 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Therapeutics 2 Tea 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Magnesium × Clear all

NCT04111848 2021-03-02

Magnesium and Ketamine in Postoperative Analgesia

National Cancer Institute, Egypt

Phase 4 Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡